Ventilator-associated pneumonia (VAP) represents one of the most common nosocomial infections in neonatal intensive care units, increasing morbidity and mortality, and associated costs. The authors report the case of a neonatal patient with VAP secondary to Chryseobacterium indologenes and a review of the literature. . The most effective empiric treatment for C. indologenes infection remains unclear due to limited data in the literature, and therefore, therapy should be adjusted in accordance with the result of the susceptibility profile.
Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.